Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1996-04-18
1999-08-17
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241471, 4243913, 4351723, 536 2353, A61K 39395, A61K 3942, C12N 1500, C07H 2104
Patent
active
059390689
ABSTRACT:
A method of detecting RSV (Respiratory Syncytial Virus) in an analyte using high affinity human monoclonal antibodies is provided.
REFERENCES:
patent: 4517304 (1985-05-01), Stott et al.
patent: 4659563 (1987-04-01), Dobkin
patent: 4717766 (1988-01-01), Dobkin
patent: 4760026 (1988-07-01), Lennox et al.
patent: 4800078 (1989-01-01), Prince et al.
patent: 4853326 (1989-08-01), Quash et al.
patent: 5071758 (1991-12-01), Stott et al.
patent: 5137804 (1992-08-01), Greene et al.
patent: 5149650 (1992-09-01), Wertz et al.
patent: 5183657 (1993-02-01), Buurman
patent: 5194595 (1993-03-01), Wathen
patent: 5219996 (1993-06-01), Bodmer et al.
patent: 5223254 (1993-06-01), Paradiso et al.
patent: 5240694 (1993-08-01), Gwaltney, Jr.
patent: 5271927 (1993-12-01), Parker et al.
patent: 5279935 (1994-01-01), Nycz
patent: 5288630 (1994-02-01), Wathen
patent: 5290540 (1994-03-01), Prince et al.
patent: 5332567 (1994-07-01), Goldenberg
patent: 5332805 (1994-07-01), Carey et al.
patent: 5340926 (1994-08-01), Lowe et al.
patent: 5354554 (1994-10-01), Rhind
patent: 5391478 (1995-02-01), Greene et al.
patent: 5412077 (1995-05-01), Siber et al.
patent: 5418136 (1995-05-01), Miller et al.
patent: 5422097 (1995-06-01), Gwaltney, Jr.
patent: 5424189 (1995-06-01), Oberst et al.
patent: 5468606 (1995-11-01), Bogart et al.
patent: 5470736 (1995-11-01), Verma et al.
patent: 5484893 (1996-01-01), Parker et al.
patent: 5506209 (1996-04-01), Mukerji et al.
patent: 5518725 (1996-05-01), Daynes et al.
patent: 5530102 (1996-06-01), Gristina et al.
patent: 5534411 (1996-07-01), Weltzin
patent: 5538733 (1996-07-01), Emery et al.
patent: 5538952 (1996-07-01), Mukerji et al.
Paul, W.E., Fundamental Immunology, Chapter 8: Immunogenicity and Antigen Structure, p. 242, 1993.
Liu et al. Co-stimulation of murine CD4 T cell growth: cooperation between B7 and heat-stable antigen. Eur. J. Immunol. Nov. 1992, vol. 22, No. 11, pp. 2855-2859.
Inaba et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. Nov. 1, 1994, vol. 180, No. 5, pp. 1849-1860.
Engel et al. The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen. Blood. Sep. 1, 1994, vol. 84, No. 5, pp. 1402-1407.
Newman et al. "Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. Biotechnology. Nov. 1992, vol. 10, No. 11, pp. 1455-1460.
Paul W., E., 1993, Fundamental Immunology, p. 242.
Seaver, 1994, Genetic Engineering News, vol. 14 (14), pp. 10 + 21.
Brams Peter
Chamat Soulaima Salim
Heard Cheryl Janne
Newman Roland Anthony
Pan Li-Zhen
Achutamurthy Ponnathapura
Idec Pharmaceuticals Corporation
Park Hankyel T.
LandOfFree
Neutralizing high affinity human monoclonal antibodies specific does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neutralizing high affinity human monoclonal antibodies specific , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing high affinity human monoclonal antibodies specific will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-313002